Tweet
PLoS One
. 2021 Feb 26;16(2):e0247429.
doi: 10.1371/journal.pone.0247429. eCollection 2021.
Avidin-biotin complex-based capture coating platform for universal Influenza virus immobilization and characterization
Micaela Trexler 1 2 , Michelle Brusatori 1 2 3 , Gregory Auner 1 2 3
Affiliations
- PMID: 33635877
- DOI: 10.1371/journal.pone.0247429
Abstract
Influenza virus mutates quickly and unpredictably creating emerging pathogenic strains that are difficult to detect, diagnose, and characterize. Conventional tools to study and characterize virus, such as next generation sequencing, genome amplification (RT-PCR), and serological antibody testing, are not adequately suited to rapidly mutating pathogens like Influenza virus where the success of infection heavily depends on the phenotypic expression of surface glycoproteins. Bridging the gap between genome and pathogenic expression remains a challenge. Using sialic acid as a universal Influenza virus binding receptor, a novel virus avidin-biotin complex-based capture coating was developed and characterized that may be used to create future diagnostic and interrogation platforms for viable whole Influenza virus. First, fluorescent FITC probe studies were used to optimize coating component concentrations. Then atomic force microscopy (AFM) was used to profile the surface characteristics of the novel capture coating, acquire topographical imaging of Influenza particles immobilized by the coating, and calculate the capture efficiency of the coating (over 90%) for all four representative human Influenza virus strains tested.